structural variant analysis
Written by early OGM adopters, the framework describes best practices for the technology's clinical implementation for hematological malignancies.
The clinical whole-genome sequencing and analysis firm is planning to add Oxford Nanopore long-read sequencing to all samples by the end of the year.
The company is also working on a new Saphyr system that will have 14 times higher throughput than the current one, which can analyze 5,000 human genomes per year.
Bionano Prices $18M Stock, Warrant Offering
The company is also participating in a study, being conducted at Hannover Medical School, investigating the genetics of susceptibility to COVID-19.
Bionano Genomics to Publicly Offer Securities, Amends Loan Agreement
The genome mapping firm had fallen out of compliance with respect to its loan agreement with Innovatus and will prepay $5 million toward the loan principal.